Please assess the completion status of the following clinical trial:

Trial Title: Study of Live, Attenuated Influenza Vaccination in Preterm and Full-Term Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Subjects must meet all relevant criteria (by time of influenza vaccination) to participate.~1. (a) Former premature (\<32 weeks' gestation at birth), VLBW (\<1500 grams' birth weight) infant, 24 months, 0 days - 35 months, 31 days of age, OR (b) Former full-term (37-42 weeks' gestation at birth), normal birth weight (\>2500 grams' birth weight) infant, 24 months, 0 days - 35 months, 31 days of age.~2. Influenza immunization in prior season.~3. Eligible for either influenza immunization (TIV or LAIV).~4. Parental permission.~5. Parents likely to be able to comply with study visits.~Exclusion Criteria:~Subjects may not participate if they meet any one of these criteria.~1. Known immunodeficiency in child or in a close household contact.~2. History of:~   * Recurrent episodes of wheezing,~  * Medically-attended wheezing illness in past year, or~  * Hospitalization for a wheezing illness.~3. Systemic corticosteroid administration at time of influenza vaccination.~4. Requiring supplemental oxygen at time of influenza vaccination.~5. Contraindication to either influenza immunization (e.g. egg allergy, aspirin therapy).~6. Physician-diagnosed influenza illness in the current influenza season.~7. Any condition determined by investigator as likely to interfere with evaluation of the vaccine or be a significant potential health risk to the subject.

- Gender: ALL
- Minimum Age: 24 Months
- Maximum Age: 35 Months
- Healthy Volunteers: t

Study Arms:
- Live attenuated influenza vaccine (Type: EXPERIMENTAL): One dose of live attenuated influenza vaccine, according to routine immunization recommendations
- Inactivated influenza vaccine (Type: ACTIVE_COMPARATOR): One dose of inactivated influenza vaccine, according to routine immunization recommendations

Based on this trial design, predict the completion outcome and termination type (if applicable).